OpenEvidence
Comparable Mobile App this size sell around 2.6x annual profit (1.6 to 3.3x, 72 comps).
- Developer
- OpenEvidence Inc.
- Genre
- Medical
- Ratings
- 10,331
- Price
- Free
- Version
- 2.9.11
Off-market target. Not listed for sale, so there are no public financials. The play is to approach the owner directly.
About
Clinical Decision Support & Medical Search Engine for Healthcare Professionals (NPI Required). OpenEvidence is trusted by hundreds of thousands of verified healthcare professionals to support high-stakes clinical decisions at the point of care with answers that are sourced, cited, and grounded in peer-reviewed medical literature. OpenEvidence is the fastest-growing and most widely-used clinical decision support platform in the world–used daily, on average, by over 40% of physicians in the United States, spanning more than 10,000 hospitals and medical centers nationwide. Now sourcing from over 300+ medical journals, as well as the FDA and CDC. OpenEvidence is an official AI partner of The New England Journal of Medicine and the Journal of American Medical Association (and their 11 specialty journals), and has content agreements, partnerships and collaborations with: NCCN ACC ADA ACEP AAFP AAOS AAOHNS and more. OpenEvidence is only available for health care professionals. Users must verify their health care professional status before using OpenEvidence. TESTIMONIALS “I've been using OpenEvidence for the last week - it has been amazing! Able to narrow down on results quickly and find information that I wasn't able to do with Google/PubMed searches on my own.” - Dr. John Lee, MD. Physician & Faculty Member, Harvard Medical School “OpenEvidence can be the foundational technology to power all clinical decision tools.” - Dr. Antonio Jorge Forte, MD. Director of MayoExpe
Traffic, trend, size, and valuation figures here are estimates, not verified by the seller. Always do your own diligence before reaching out or making an offer.